As of April 15, 2019, the following activity does not meet the requirement for stand-alone training for certification required to obtain a waiver and is only to be used as supplementary education. Participants can earn a Letter of Completion only.
Waiver Exemption. On 1/12/2021, the U.S. DHHS announced an exemption to the training requirement for prescribing buprenorphine for opioid use disorder or detoxification for physicians having a DEA registration. A subsequent Washington Post news report 1/25/2021 reported the change may be reconsidered due to legal considerations.
Buprenorphine Education: Historical
Goal: To provide training to providers in order to increase knowledge about prescribing buprenorphine to their patients with opioid use disorder.
This activity is designed to change: Competence, Performance, Patient Outcome. 9 hr(s)
After completing this activity participants will be able to:
- Expand your practice to comply with the regulations and requirements of office-based buprenorphine treatment so that you can prescribe buprenorphine to your patients when appropriate
- Relate buprenorphine’s pharmacological properties to its drug effects and understand the physiological effects of opioids and opioid treatments on patients
- Identify, assess, and diagnose opioid use disorder in your patients
- Use medical and substance use disorder history information to assess your patients in terms of suitability for treatment with buprenorphine
- Provide effective and successful treatment to your patients throughout the phases of buprenorphine treatment: induction, maintenance, and discontinuation, and deal with complications that arise
- Assess and adapt treatment guidelines to best treat your patients from specific patient populations, including those with psychiatric comorbidities, adolescents, the elderly, pregnant women, methadone transfers, and patients with pain
- Prescribe, refer, or implement appropriate psychosocial therapies for treating opioid use disorder for your patients
Modules in this Training Activity
Audience and Accreditation
Audience: Medical Residents, Medical Students
A letter of completion for 9 hours is available.
A score of 70% on the post-test is required to complete the activity.
Initial development of this activity was supported by a grant from the National Institute on Drug Abuse (#R44-DA12066).